CST for Patients - EpiSwitch CST

EpiSwitch COVID Severity Test is an advanced blood test that measures YOUR likelihood of a severe response if you are infected by SARS-CoV-2.

Watch video to learn moreGet The Test
EpiSwitch CST assesses the risk that COVID-19 poses to an individual.

Many people have questions about how the COVID-19 pandemic may affect them. “What will happen if I get infected?” “Will I have a severe immune response?” “Am I at risk for being hospitalized?”

EpiSwitch CST is the first and only commercially-available blood test for the prediction of COVID-19 severity in ANY adult, independent of COVID-19 status.

The test is designed to provide your healthcare provider (HCP) and you with actionable decision-making information to reduce your risk during the COVID-19 pandemic based on your unique 3D genetic immune profile.

How EpiSwitch CST can help
Understanding YOUR risk of a severe immune response and potential for hospitalization is key to assisting you and your HCP’s strategy for avoiding infection, and making treatment decisions where necessary. Additionally, many people experience greater peace of mind the more they know about their health.

MANAGE THE UNCERTAINTY OF DAILY LIFE

With so many uncertainties imposed by the COVID-19 pandemic, EpiSwitch CST provides actionable information you can use in your daily life.

IDENTIFY RISK OF DEVELOPING A SEVERE IMMUNE RESPONSE

Go beyond the limits of basic clinical risk factors and understand your immunogenetic risk.

INFORM PREVENTIVE LIFESTYLE DECISIONS

EpiSwitch CST provides critical information you can apply to everyday decisions regarding infection prevention.

EMPOWER VACCINATION DECISIONS

With multiple vaccine options now available, EpiSwitch CST can help you and your HCP make a vaccination plan.

INSTILL THE CONFIDENCE TO SAFELY RETURN TO WORK

Should I return to work? Am I safer working from home? Let EpiSwitch CST help guide your decision.

INFORM YOUR HCP’s ASSESSMENT

In combination with your HCP’s clinical assessment, EpiSwitch CST gives you the confidence to fully understand your level of risk.
Features of EpiSwitch CST
EpiSwitch CST delivers essential information based on genetic markers to aid in determining an individual’s risk of severe immune response requiring critical care due to COVID-19.

EpiSwitch CST is the first and only prognostic blood test that can predict a severe immune response to future COVID-19 infection.

Helps identify individuals who would most likely require critical care.

Can be used by any adult, independent of their COVID-19 status––including those who have never been infected, those who have been infected, or those who are currently infected.

Conventional COVID-19 tests can only detect infection with SARS-CoV-2. They cannot predict whether an individual will have a severe immune response to COVID-19.

Knowledge of the EpiSwitch CST score allows HCPs and patients to formulate an effective management plan.

A molecular test that uses routine blood draws with results in 48-72 hours.

How does the EpiSwitch CST report work?

The EpiSwitch CST report provides an easy-to-understand assessment of risk for a severe immune response to COVID-19.

Sample Results of EpiSwitch CST

EpiSwitch CST provides an essential personalized measure of the risk of severe illness due to COVID-19.

 

Patient risk is presented as a single, easy-to-read EpiSwitch CST score, assessing the prognosis of patients if they become infected with SARS-CoV-2.

 

EpiSwitch CST includes clear guidance for interpretation of the Risk Score by a healthcare professional – Decisions on care and treatment should be based on the independent medical judgment of the treating HCP, EpiSwitch CST includes clear guidance for interpretation of the Risk Score by a healthcare professional – Decisions on care and treatment should be based on the independent medical judgment of the treating HCP, taking into consideration all available information. taking into consideration all available information.

How to Get the EpiSwitch CST
Complete the Requisition Form and take it to your HCP today.
Patient FAQs